3.21 USD
0.04
1.23%
Last update Dec 15, 1:48 PM EST
Main market
Day range
3.21
3.38
Previous close
3.25
Open
3.33
Access this stock data via API
Subscribe
Aclaris Therapeutics Inc.
3.21
0.04
1.23%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 18.7M 31.2M 29.8M 6.8M
Cost of revenue 15.5M 18.1M 12.0M 4.7M
Gross profit 3.3M 13.2M 17.8M 2.0M
Operating expense
Research & development 33.6M 98.4M 77.8M 43.8M
Selling general and admin 22.2M 31.1M 25.1M 23.6M
Other operating expenses
Operating income -52.5M -116.3M -85.2M -65.4M
Non operating interest income
Income
Expense
Other income expense -79.5M 27.5M -1.8M -25.5M
Pretax income -132.1M -88.8M -86.9M -90.9M
Tax provision 0 -367K 0 0
Net income -132.1M -88.5M -86.9M -90.9M
Basic EPS -1.7 -1.3 -1.3 -1.6
Diluted EPS -1.7 -1.3 -1.3 -1.6
Basic average shares 77.3M 69.8M 65.2M 56.7M
Diluted average shares 77.3M 69.8M 65.2M 56.7M
EBITDA 37.7M -134.4M -79.7M -40.1M
Net income from continuing op. -132.1M -88.5M -86.9M -90.9M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 2 hours 10 minutes

13:49
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).